Healthcare "Rationing" Not Acceptable Reason For Denying Switches - FDAer
This article was originally published in The Tan Sheet
Executive Summary
The practice of "rationing" a drug, or wanting to keep it out of the hands of the general public, is not an acceptable singular reason for disapproving a switch candidate, FDA Office of Drug Evaluation V Director Robert DeLap, MD/PhD, stated at a switch summit held by the Consumer Healthcare Products Association July 16 in Washington, D.C.
You may also be interested in...
Rx-To-OTC Switch Candidate Negative Lists "Stifle Innovation" - CHPA
FDA should consider all Rx-to-OTC switch candidates on a case-by-case basis and avoid creating "presumptive negative lists" of drug classes not suited to OTC use, the Consumer Healthcare Products Association stresses in Aug. 25 comments to the agency.
Rx-To-OTC Switch Candidate Negative Lists "Stifle Innovation" - CHPA
FDA should consider all Rx-to-OTC switch candidates on a case-by-case basis and avoid creating "presumptive negative lists" of drug classes not suited to OTC use, the Consumer Healthcare Products Association stresses in Aug. 25 comments to the agency.
Rx-To-OTC Switch Candidate Negative Lists "Stifle Innovation" - CHPA
FDA should consider all Rx-to-OTC switch candidates on a case-by-case basis and avoid creating "presumptive negative lists" of drug classes not suited to OTC use, the Consumer Healthcare Products Association stresses in Aug. 25 comments to the agency.